OA06.03 Patient-Reported Outcomes from ADAURA: Osimertinib as Adjuvant Therapy in Patients with Resected EGFR Mutated (EGFRm) NSCLC
暂无分享,去创建一个
M. Tsuboi | R. Herbst | Yi-long Wu | F. Shepherd | T. John | J. Goldman | M. Dómine | S. Kim | T. Kato | L. Bonanno | M. Majem | F. Marinis | D. Kulkarni | C. Akewanlop | L. Zeng | K. Y. Lee | C. Yu | H. Vu | S. Lu | C. Grohé | Konstantin Laktionov | N. Medić